SI-BONE, Inc. (SIBN) vs SL Science Holding Ltd (SLBT)
A side-by-side comparison of SI-BONE, Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SIBN
SI-BONE, Inc.
$19.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLBT
SL Science Holding Ltd
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SIBN vs SLBT
growth of $100 · dividends reinvested · last 1ySIBN +35.7% (+35.7%/yr)SLBT -79.6% (-79.6%/yr)SIBN compounded faster over this window
Log scale — wide-divergence pair
SIBN SLBT
SIBN vs SLBT: by the numbers
- •SIBN is the larger company ($867M vs $852M market cap).
- •Both run net losses; SIBN's is the smaller (-6.85% vs -173.85% net margin).
Metrics side by side
Valuation
| Metric | SIBN | SLBT |
|---|---|---|
| P/S ratio | 4.06 | N/A |
| P/B ratio | 4.75 | 373.20 |
Profitability
| Metric | SIBN | SLBT |
|---|---|---|
| Gross margin | 79.53% | 35.27% |
| Operating margin | -8.31% | -174.65% |
| Net margin | -6.85% | -173.85% |
| ROE | -8.03% | -167.25% |
| ROIC | -7.88% | -163.39% |
Growth (annualized)
| Metric | SIBN | SLBT |
|---|---|---|
| Revenue CAGR (5Y) | 20.20% | N/A |
| Total return CAGR (5Y) | -1.46% | N/A |
Go deeper
Dig into the metrics
SI-BONE ROESL Science ROESI-BONE operating marginSL Science operating marginSI-BONE revenue growthSL Science revenue growthSI-BONE free cash flowSL Science free cash flow
SI-BONE & SL Science appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.